Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01271712||Active, not recruiting
|Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)||
||199||All||18 Years and older (Adult, Senior)||NCT01271712||14874
|GRID||January 4, 2011||January 26, 2012||December 31, 2018||January 7, 2011||May 15, 2018||October 25, 2013||